Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Consensus Target Price from Analysts

Shares of Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $12.95.

Several brokerages have recently commented on AMTX. StockNews.com upgraded shares of Aemetis to a "sell" rating in a report on Monday, January 27th. HC Wainwright reiterated a "buy" rating and issued a $28.00 target price on shares of Aemetis in a report on Monday, December 23rd.

Aemetis Stock Down 6.9 %

AMTX traded down $0.16 during trading on Friday, hitting $2.15. 645,421 shares of the company's stock were exchanged, compared to its average volume of 814,401. The business's 50 day moving average is $2.93 and its two-hundred day moving average is $2.88. Aemetis has a fifty-two week low of $2.04 and a fifty-two week high of $7.03. The stock has a market cap of $106.94 million, a P/E ratio of -0.95 and a beta of 1.44.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the previous year, the company posted ($0.59) EPS. On average, sell-side analysts forecast that Aemetis will post -2.07 earnings per share for the current year.

Hedge Funds Weigh In On Aemetis

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AMTX. State Street Corp boosted its position in Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company's stock worth $1,608,000 after purchasing an additional 185,304 shares during the period. Susquehanna Fundamental Investments LLC boosted its position in Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company's stock worth $379,000 after purchasing an additional 93,536 shares during the period. Wellington Management Group LLP bought a new position in Aemetis during the third quarter worth about $177,000. Geode Capital Management LLC boosted its position in Aemetis by 7.7% during the third quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company's stock worth $2,126,000 after purchasing an additional 66,031 shares during the period. Finally, Barclays PLC boosted its position in Aemetis by 274.6% during the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company's stock worth $109,000 after purchasing an additional 34,816 shares during the period. Institutional investors own 27.02% of the company's stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.